Clinical Oncology Next Generation Sequencing Ngs Market Size And Share

  • Report Code : TIPRE00007163
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Clinical Oncology Next Generation Sequencing Market Size 2031

Buy Now

Clinical Oncology Next Generation Sequencing (NGS) Market Report Clinical Oncology Next Generation Sequencing (NGS) Market Scope and Analysis Clinical Oncology Next Generation Sequencing (NGS) Market Size and Share

Clinical Oncology Next Generation Sequencing (NGS) Market Report Analysis

Clinical Oncology Next Generation Sequencing (NGS) Market

  • CAGR (2025 - 2031)
    XX%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Agilent Technologies Inc
  • Caris Life Sciences
  • F Hoffmann La Roche Ltd
  • FOUNDATION MEDICINE INC
  • Illumina Inc
  • Myriad Genetics Inc
  • Oxford Nanopore Technologies
  • PerkinElmer Inc
  • QIAGEN

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Technology
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Targeted Sequencing and Resequencing
By Workflow
  • NGS Data Analysis
  • NGS Pre-Sequencing
  • NGS Sequencing
By Application
  • Companion Diagnostics
  • Screening
  • Other Applications
By End User
  • Hospitals and Clinics
  • Laboratories